PCM
DGX icon

Penserra Capital Management’s Quest Diagnostics DGX Stock Holding History

Penserra Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Buy
6,261
+6,255
+104,250% +$1.22M 0.01% 423
2025
Q4 		$1K Buy
+6
New +$1.09K ﹤0.01% 1015
2025
Q1 		– Sell
-283
Closed -$42K – 1071
2024
Q4 		$42K Buy
283
+274
+3,044% +$42.6K ﹤0.01% 951
2024
Q3 		$1K Buy
9
+3
+50% +$448 ﹤0.01% 1063
2024
Q2 		$1K Hold
6
– – ﹤0.01% 1217
2024
Q1 		$0 Sell
6
-512
-99% -$66.4K ﹤0.01% 1286
2023
Q4 		$70K Sell
518
-108
-17% -$14.2K ﹤0.01% 941
2023
Q3 		$75K Sell
626
-101
-14% -$13.5K ﹤0.01% 941
2023
Q2 		$101K Buy
727
+504
+226% +$69.5K ﹤0.01% 937
2023
Q1 		$30K Sell
223
-18,865
-99% -$2.7M ﹤0.01% 880
2022
Q4 		$2.98M Buy
+19,088
New +$2.74M 0.07% 278
2020
Q2 		– Sell
-975
Closed -$109K – 826
2020
Q1 		$109K Buy
975
+51
+6% +$5.28K 0.01% 546
2019
Q4 		$103K Buy
924
+198
+27% +$20.6K 0.01% 586
2019
Q3 		$77K Buy
726
+264
+57% +$27.1K 0.01% 590
2019
Q2 		$47K Buy
462
+18
+4% +$1.73K ﹤0.01% 598
2019
Q1 		$42K Buy
+444
New +$38.5K ﹤0.01% 553
2017
Q1 		– Sell
-282
Closed -$25K – 626
2016
Q4 		$25K Buy
282
+61
+28% +$5.26K ﹤0.01% 511
2016
Q3 		$18K Buy
221
+88
+66% +$7.39K ﹤0.01% 564
2016
Q2 		$11K Buy
133
+44
+49% +$3.35K ﹤0.01% 574
2016
Q1 		$6 Sell
89
-5
-5% -$335 ﹤0.01% 622
2015
Q4 		$7K Buy
+94
New +$6.32K ﹤0.01% 615

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Penserra Capital Management's DGX Position: Q1 2026 in Review

Penserra Capital Management increased its Quest Diagnostics (DGX) stake by 104,250% in Q1 2026, buying an estimated $1.22M and bringing the position to 6,261 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #423.

Penserra Capital Management first reported a position in DGX in Q4 2015 and has held it in 21 quarters since. The position peaked at $2.98M in Q4 2022. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Penserra Capital Management held 6,261 shares of Quest Diagnostics worth $1.23M as of Q1 2026.
  • Penserra Capital Management bought 6,255 Quest Diagnostics shares in Q1 2026, an estimated $1.22M.
  • Quest Diagnostics made up 0.01% of Penserra Capital Management's portfolio in Q1 2026, its #423 holding.
  • Penserra Capital Management first reported a position in Quest Diagnostics in Q4 2015 and has held it in 21 quarters since.
  • Penserra Capital Management's Quest Diagnostics position peaked at $2.98M in Q4 2022.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Penserra Capital Management's 13F filing for Q1 2026, filed 11 May 2026.